Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Curry

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 13, 2013
A simultaneous liver-kidney transplant recipient with IgA nephropathy limited to native kidneys and BK virus nephropathy limited to the transplant kidneyManasa P Ujire, Michael P Curry, Isaac E Stillman, et al.
Abdominal Radiology (New York)|July 31, 2016
Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk ScoreJennifer M Ni Mhuircheartaigh, Karen S Lee, Michael P Curry, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|December 7, 2013
Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status changeJames R Rodrigue, David R Nelson, Douglas W Hanto, et al.
Annals of Hepatology|March 7, 2023
Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1cHirsh D Trivedi, Qua Tran, Zachary Fricker, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 8, 2011
Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?James R Rodrigue, David R Nelson, Alan I Reed, et al.
Clinical Anatomy (New York, N.Y.)|August 28, 2023
Angiography with cone-beam CT versus contrast-enhanced MRI for living donor transplant imaging: Is MRI enough?Hamza Ali, Jeffrey Weinstein, Ammar Sarwar, et al.
Cardiology in Review|October 5, 2019
Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized ApproachDonya Mohebali, Anne-Marie Anagnostopoulos, Alisson Estrada-Roman, et al.
Academic Radiology|March 16, 2015
Pulmonary Vessel Cross-sectional Area before and after Liver Transplantation: Quantification with Computed TomographyHilary M DuBrock, Alexander A Bankier, Mario Silva, et al.
Journal of Managed Care & Specialty Pharmacy|June 9, 2021
Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational studyMichael P Curry, Steven L Flamm, Scott Milligan, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2022
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failureFlorence Wong, Stephen Chris Pappas, K Rajender Reddy, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 13, 2013
A simultaneous liver-kidney transplant recipient with IgA nephropathy limited to native kidneys and BK virus nephropathy limited to the transplant kidneyManasa P Ujire, Michael P Curry, Isaac E Stillman, et al.
Abdominal Radiology (New York)|July 31, 2016
Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk ScoreJennifer M Ni Mhuircheartaigh, Karen S Lee, Michael P Curry, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|December 7, 2013
Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status changeJames R Rodrigue, David R Nelson, Douglas W Hanto, et al.
Annals of Hepatology|March 7, 2023
Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1cHirsh D Trivedi, Qua Tran, Zachary Fricker, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 8, 2011
Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?James R Rodrigue, David R Nelson, Alan I Reed, et al.
Clinical Anatomy (New York, N.Y.)|August 28, 2023
Angiography with cone-beam CT versus contrast-enhanced MRI for living donor transplant imaging: Is MRI enough?Hamza Ali, Jeffrey Weinstein, Ammar Sarwar, et al.
Cardiology in Review|October 5, 2019
Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized ApproachDonya Mohebali, Anne-Marie Anagnostopoulos, Alisson Estrada-Roman, et al.
Academic Radiology|March 16, 2015
Pulmonary Vessel Cross-sectional Area before and after Liver Transplantation: Quantification with Computed TomographyHilary M DuBrock, Alexander A Bankier, Mario Silva, et al.
Journal of Managed Care & Specialty Pharmacy|June 9, 2021
Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational studyMichael P Curry, Steven L Flamm, Scott Milligan, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2022
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failureFlorence Wong, Stephen Chris Pappas, K Rajender Reddy, et al.
Pageof 9